
Neeraj Sharma
Examiner (ID: 5222, Phone: (571)270-5487 , Office: P/2659 )
| Most Active Art Unit | 2659 |
| Art Unit(s) | 2659, 2626 |
| Total Applications | 582 |
| Issued Applications | 475 |
| Pending Applications | 51 |
| Abandoned Applications | 71 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6406533
[patent_doc_number] => 20020182698
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-12-05
[patent_title] => 'Mutated steroid hormone receptors, methods for their use and molecular switch for gene therapy'
[patent_app_type] => new
[patent_app_number] => 10/124739
[patent_app_country] => US
[patent_app_date] => 2002-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 22326
[patent_no_of_claims] => 86
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0182/20020182698.pdf
[firstpage_image] =>[orig_patent_app_number] => 10124739
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/124739 | Mutated steroid hormone receptors, methods for their use and molecular switch for gene therapy | Apr 15, 2002 | Abandoned |
Array
(
[id] => 467534
[patent_doc_number] => 07235523
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-06-26
[patent_title] => 'Methods for the treatment of hepatic disorders'
[patent_app_type] => utility
[patent_app_number] => 10/123036
[patent_app_country] => US
[patent_app_date] => 2002-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13365
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 174
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/235/07235523.pdf
[firstpage_image] =>[orig_patent_app_number] => 10123036
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/123036 | Methods for the treatment of hepatic disorders | Apr 14, 2002 | Issued |
Array
(
[id] => 5677841
[patent_doc_number] => 20060183197
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-17
[patent_title] => 'Variant growth hormone molecules conjugated with macromolecules compounds'
[patent_app_type] => utility
[patent_app_number] => 10/250800
[patent_app_country] => US
[patent_app_date] => 2002-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25707
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0183/20060183197.pdf
[firstpage_image] =>[orig_patent_app_number] => 10250800
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/250800 | Variant growth hormone molecules conjugated with macromolecules compounds | Jan 9, 2002 | Abandoned |
Array
(
[id] => 7170341
[patent_doc_number] => 20040077828
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-04-22
[patent_title] => 'Sfrp and peptide motifs that interact with sfrp and methods of their use'
[patent_app_type] => new
[patent_app_number] => 10/466136
[patent_app_country] => US
[patent_app_date] => 2003-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 22612
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0077/20040077828.pdf
[firstpage_image] =>[orig_patent_app_number] => 10466136
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/466136 | SFRP and peptide motifs that interact with SFRP and methods of their use | Jan 9, 2002 | Issued |
| 10/019785 | Remedies for drug-resistant hypercalcemia | Jan 3, 2002 | Abandoned |
Array
(
[id] => 880028
[patent_doc_number] => 07354901
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-04-08
[patent_title] => 'Production of recombinant BMP-2'
[patent_app_type] => utility
[patent_app_number] => 10/433077
[patent_app_country] => US
[patent_app_date] => 2001-11-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 11
[patent_no_of_words] => 9000
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/354/07354901.pdf
[firstpage_image] =>[orig_patent_app_number] => 10433077
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/433077 | Production of recombinant BMP-2 | Nov 26, 2001 | Issued |
Array
(
[id] => 7363955
[patent_doc_number] => 20040005554
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-01-08
[patent_title] => 'Novel glycoproteins and methods of use thereof'
[patent_app_type] => new
[patent_app_number] => 09/927876
[patent_app_country] => US
[patent_app_date] => 2001-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 52
[patent_figures_cnt] => 52
[patent_no_of_words] => 46195
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0005/20040005554.pdf
[firstpage_image] =>[orig_patent_app_number] => 09927876
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/927876 | Novel glycoproteins and methods of use thereof | Aug 9, 2001 | Abandoned |
Array
(
[id] => 345110
[patent_doc_number] => 07498297
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-03-03
[patent_title] => 'Medicinal uses of mu-opioid receptor agonists'
[patent_app_type] => utility
[patent_app_number] => 10/333485
[patent_app_country] => US
[patent_app_date] => 2001-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 8950
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/498/07498297.pdf
[firstpage_image] =>[orig_patent_app_number] => 10333485
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/333485 | Medicinal uses of mu-opioid receptor agonists | Jul 17, 2001 | Issued |
Array
(
[id] => 541103
[patent_doc_number] => 07169603
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-01-30
[patent_title] => 'α-MSH related compounds and methods of use'
[patent_app_type] => utility
[patent_app_number] => 09/906206
[patent_app_country] => US
[patent_app_date] => 2001-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 31
[patent_no_of_words] => 19094
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/169/07169603.pdf
[firstpage_image] =>[orig_patent_app_number] => 09906206
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/906206 | α-MSH related compounds and methods of use | Jul 15, 2001 | Issued |
Array
(
[id] => 641645
[patent_doc_number] => 07122344
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-10-17
[patent_title] => 'Methods for the production of purified recombinant human uteroglobin for the treatment of inflammatory and fibrotic conditions'
[patent_app_type] => utility
[patent_app_number] => 09/898616
[patent_app_country] => US
[patent_app_date] => 2001-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 35
[patent_figures_cnt] => 36
[patent_no_of_words] => 19680
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/122/07122344.pdf
[firstpage_image] =>[orig_patent_app_number] => 09898616
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/898616 | Methods for the production of purified recombinant human uteroglobin for the treatment of inflammatory and fibrotic conditions | Jul 1, 2001 | Issued |
Array
(
[id] => 7607532
[patent_doc_number] => 07098183
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-08-29
[patent_title] => 'Nucleotide and amino acid sequences of oocyte factors for altering ovarian follicular growth in vivo or in vitro'
[patent_app_type] => utility
[patent_app_number] => 10/311664
[patent_app_country] => US
[patent_app_date] => 2001-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 10691
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/098/07098183.pdf
[firstpage_image] =>[orig_patent_app_number] => 10311664
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/311664 | Nucleotide and amino acid sequences of oocyte factors for altering ovarian follicular growth in vivo or in vitro | Jun 14, 2001 | Issued |
Array
(
[id] => 823701
[patent_doc_number] => 07405193
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-07-29
[patent_title] => 'Use of Acrp30 globular head to promote increases in muscle mass and muscle differentiation'
[patent_app_type] => utility
[patent_app_number] => 10/296865
[patent_app_country] => US
[patent_app_date] => 2001-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 8
[patent_no_of_words] => 13197
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 124
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/405/07405193.pdf
[firstpage_image] =>[orig_patent_app_number] => 10296865
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/296865 | Use of Acrp30 globular head to promote increases in muscle mass and muscle differentiation | May 21, 2001 | Issued |
Array
(
[id] => 382979
[patent_doc_number] => 07306931
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-12-11
[patent_title] => 'Method for refolding proteins containing free cysteine residues'
[patent_app_type] => utility
[patent_app_number] => 10/276358
[patent_app_country] => US
[patent_app_date] => 2001-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44837
[patent_no_of_claims] => 49
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 197
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/306/07306931.pdf
[firstpage_image] =>[orig_patent_app_number] => 10276358
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/276358 | Method for refolding proteins containing free cysteine residues | May 15, 2001 | Issued |
Array
(
[id] => 6648642
[patent_doc_number] => 20030104553
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-05
[patent_title] => 'Process of purification of hcg and recombinant hcg purified by that method'
[patent_app_type] => new
[patent_app_number] => 10/204630
[patent_app_country] => US
[patent_app_date] => 2002-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3745
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0104/20030104553.pdf
[firstpage_image] =>[orig_patent_app_number] => 10204630
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/204630 | Process of purification of hCG and recombinant hCG purified by that method | Jan 21, 2001 | Issued |
Array
(
[id] => 369875
[patent_doc_number] => 07476648
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2009-01-13
[patent_title] => 'Vessel embolic material comprising hydrogel and therapy with the use thereof'
[patent_app_type] => utility
[patent_app_number] => 10/111483
[patent_app_country] => US
[patent_app_date] => 2000-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 9
[patent_no_of_words] => 3178
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/476/07476648.pdf
[firstpage_image] =>[orig_patent_app_number] => 10111483
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/111483 | Vessel embolic material comprising hydrogel and therapy with the use thereof | Oct 25, 2000 | Issued |
Array
(
[id] => 91719
[patent_doc_number] => 07732157
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2010-06-08
[patent_title] => 'Soluble epidermal growth factor receptor-like proteins and their uses in cancer detection methods'
[patent_app_type] => utility
[patent_app_number] => 09/676380
[patent_app_country] => US
[patent_app_date] => 2000-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 19586
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 266
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/732/07732157.pdf
[firstpage_image] =>[orig_patent_app_number] => 09676380
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/676380 | Soluble epidermal growth factor receptor-like proteins and their uses in cancer detection methods | Sep 28, 2000 | Issued |
Array
(
[id] => 448358
[patent_doc_number] => 07250297
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2007-07-31
[patent_title] => 'Anticalins'
[patent_app_type] => utility
[patent_app_number] => 09/509444
[patent_app_country] => US
[patent_app_date] => 1998-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 15678
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 289
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/250/07250297.pdf
[firstpage_image] =>[orig_patent_app_number] => 09509444
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/509444 | Anticalins | Sep 24, 1998 | Issued |
Array
(
[id] => 847051
[patent_doc_number] => 07384751
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2008-06-10
[patent_title] => 'Methods of diagnosing muscle damage'
[patent_app_type] => utility
[patent_app_number] => 09/115589
[patent_app_country] => US
[patent_app_date] => 1998-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 17243
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/384/07384751.pdf
[firstpage_image] =>[orig_patent_app_number] => 09115589
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/115589 | Methods of diagnosing muscle damage | Jul 14, 1998 | Issued |
| 08/786937 | LHRH-ANTAGONISTS IN THE TREATMENT OF FERTILITY DISORDERS | Jan 21, 1997 | Abandoned |